Goel Shubh 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Dec 20, 2021
Insider Transaction Report
Form 4
Goel Shubh
Chief Commercial Officer
Transactions
- Award
Restricted Share Unit (right to receive value of a share)
2021-12-20+37,500→ 37,500 totalExercise: $0.00Exp: 2031-12-20→ Common Shares (37,500 underlying) - Award
Stock Option (right to buy)
2021-12-20+75,000→ 75,000 totalExercise: $4.08Exp: 2031-12-20→ Common Shares (75,000 underlying)
Footnotes (3)
- [F1]On December 20, 2021, Shubh Goel was granted an incentive stock option to purchase 75,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F2]On December 20, 2021, Shubh Goel was granted restricted share units to receive 37,500 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
- [F3]Item vests 100% upon FDA approval of PEDMARKTM.